US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
アメリカ
NYSE
Chimera Investment Corporation New (CIM-B) 銘柄情報

Chimera Investment Corporation New (CIM-B)

23.75

0.385

(1.65%)

終了 7月3日 5:00AM

23.75

0.00

(0.00%)

取引時間後: 5:10AM

Chimera Investment Corporation New (CIM-B) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

23.75

( 1.65% )

買値

-

売値

-

出来高

20,413

23.32 日の範囲 23.75

0.00 52 週間の範囲 0.00

時価総額

前日終値

23.36

始値

23.44

時刻

最終取引時間

財務取引量

US$ 481,203

VWAP

23.57

平均取引量 (3 か月)

US$ 710,366

発行済株式数

83,646,018

配当利回り

1.56 (13.40%)

PER

-16.98

1 株当たり利益 (EPS)

-0.81

歳入

214.9M

純利益

19.29M

Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. It operates in two segments, Investment Portfolio and Residential Origination. The company, through its subsidiaries, invests in, originates, and manages a portfolio of mortgage assets, including r... Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. It operates in two segments, Investment Portfolio and Residential Origination. The company, through its subsidiaries, invests in, originates, and manages a portfolio of mortgage assets, including residential mortgage loans, non-agency mortgage-backed securities, agency mortgage-backed securities, business purpose loans, investor loans, mortgage servicing rights, and other real estate-related assets. It also invests in investment grade, non-investment grade, and non-rated securities. In addition, the company offers third-party advisory services. The company qualifies as a REIT for federal income tax purposes. As a REIT, it intends to distribute at least 90% of its taxable income as dividends to shareholders. Chimera Investment Corporation was incorporated in 2007 and is headquartered in New York, New York. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.chimerareit.com

本社

New York, United States

設立

2026

Chimera Investment Corporation New is listed in the sector of the ニューヨーク証券取引所 with ticker CIM-B. The last closing price for Chimera Investment was US$23.36. Over the last year, Chimera Investment shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Chimera Investment currently has 83,646,018 shares in issue. The market capitalisation of Chimera Investment is US$1.99 billion. Chimera Investment has a price to earnings ratio (PE ratio) of -16.98.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	PR
4	0	0	0	0	0	0	0	PR
12	0	0	0	0	0	0	0	PR
26	0	0	0	0	0	0	0	PR
52	0	0	0	0	0	0	0	PR
156	0	0	0	0	0	0	0	PR
260	0	0	0	0	0	0	0	PR

CIM-B - Frequently Asked Questions (FAQ)

What is the current Chimera Investment Corporation New share price?

The current share price of Chimera Investment Corporation New is US$ 23.75

How many Chimera Investment Corporation New shares are in issue?

Chimera Investment Corporation New has 83,646,018 shares in issue

What is the market cap of Chimera Investment Corporation New?

The market capitalisation of Chimera Investment Corporation New is USD 1.99B

What is the 1 year trading range for Chimera Investment Corporation New share price?

Chimera Investment Corporation New has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Chimera Investment Corporation New?

The price to earnings ratio of Chimera Investment Corporation New is -16.98

What is the cash to sales ratio of Chimera Investment Corporation New?

The cash to sales ratio of Chimera Investment Corporation New is 5.33

What is the registered address of Chimera Investment Corporation New?

The registered address for Chimera Investment Corporation New is One Rockefeller Plaza, New York, New York, 10020

What is the Chimera Investment Corporation New website address?

The website address for Chimera Investment Corporation New is www.chimerareit.com

uuiyami1

uuiyami1 4分前

DocLee

Today's the day and the hour is 11.13am BST (= 10.10am GMT) so Dr Bosch should be well into his stride.BETHESDA, Md., July 2, 2026 -- Northwest Biotherapeutics (OTCQB:NWBO) (the “Company” or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancer

eagle8

eagle8 10分前

RIP_GOP
@RIP_GOP1234
$NWBO #DCVAX 😎👇🏽

https://prnewswire.com/news-releases/high-grade-glioma-market-witnesses-strong-momentum-during-the-forecast-period-20262036-with-increasing-clinical-activity-and-drug-development--delveinsight-302815434.html

eagle8

eagle8 13分前

Justin Keister MS DABR
@justinkeister5
Irrefutable evidence of the successes of personalized dendritic cell vaccination? This would be the forum to tell surgeons how to keep GBM patients alive longer and, in some cases, potentially cure this disease.

$NWBO
Quote

uuiyami1

uuiyami1 14分前

I experienced a crazy stroke of luck when a cheap retail stock blew up, but confidence quickly turned into a financial nightmare. Desperate to scale my account into a life-changing fortune, I rolled all my winnings into an medical technology stock right before a major class-action lawsuit forced a g

shajandr

shajandr 15分前

HGENQ has no management; it only has a bankruptcy trustee/receiver for liquidation.

There are no officers and no directors. Humanigen is inliquidation bankruptcy. Further, in corporate liquidation bankruptcies, debts are nott discharged, the unpaid debts remain forever - ergo the corp

floblu14

floblu14 16分前

Additional info re: Dew's post -

Enanta Pharmaceuticals intends to offer and sell up to $75,000,000 of its common stock through an Open Market Sale (sales agreement) with Jefferies LLC as sales agent under an at-the-market offering structure. The sales agreement permits sales from tim

uuiyami1

uuiyami1 18分前

I lost exactly €4,700 after a sudden geopolitical blockade paralyzed a major maritime shipping route overnight. I had moved my active portfolio capital into global logistics shares based on basic online sentiment, completely lacking the structural market knowledge to manage the trade. I watched my e

uuiyami1

uuiyami1 19分前

I’ve been trading stocks since COVID, but without real execution rules, my account was just a slow capital bleed. Desperate to make more money, I followed a loud discussion on a stock website and shifted my savings into an agricultural supplier equity right before unexpected seasonal weather complet

uuiyami1

uuiyami1 21分前

Ever since the initial market craze of 2020, my trading journey has been a continuous narrative of slow capital decay. Desperate to engineer a rapid recovery, I put my remaining savings into an aerospace engineering stock right before a critical competitor successfully challenged their primary defen

gregcod

gregcod 22分前

Hi Trader maybe if you would post that report and paste it to here for investors to see.dont want to keep this quiet..or maybe i should stay quiet?? the link is again,
AInvest.com/news/ibat-Q4update..US Mag..all things concidered..All things possible.

uuiyami1

uuiyami1 22分前

I lost exactly €6,500 after a sudden legislative shift canceled a massive government contract for a specialized cloud data provider I held. I bought the shares based on basic online chatter, completely lacking the structural market knowledge to manage structural regulatory risks. The stock plummeted

uuiyami1

uuiyami1 24分前

As a total beginner in the stock market, I spent months quietly buying shares based purely on news headlines and social media hype. I poured over €5,800 of my core savings into a mineral extraction company right before a surprise foreign regulatory ban paralyzed their main processing facility. I wat

iHub News

iHub News 50分前

U.S. holiday pause, softer Fed expectations and Asia rebound shape global markets: Dow Jones, S&P, Nasdaq, Wall Street FuturesJuly 3, 2026 5:19 AM
IH Market News

iHub News

iHub News 50分前

Tesla’s strong Q2 deliveries lift Chinese supplier sharesJuly 3, 2026 5:21 AM
IH Market News Tesla (NASDAQ:TS

Ace Trader

Ace Trader 50分前

I wonder if they are fishing for evidence for an appeal to SCOTUS if they lose this verdict coming this month.? What's the bottom line for sending in Pulte to dig up dirt ??? The 11,000 docs ? or more mortgage fraud ??

jxyzobrien

jxyzobrien 53分前

sector rotation
https://www.youtube.com/watch?v=7G9qvhO7AR8

Dram caused NDX selling friday

NDX
https://stockcharts.com/sc3/ui/?s=%24NDX&a=2094034028

Ace Trader

Ace Trader 53分前

Agreed !
They have changed their tune from release to maybe to No rush. So what's it going to be next month? I think they are either building a master plan for the SWF or its a release as DJT walks out the door and a big win for all that donated and his buddies. This will be a big win for sha

eagle8

eagle8 54分前

flipper,
could it be that those 10-year survival rates from DCvax, which you've talked about a lot, are also going to be included in this ( Dr. Bosch) presentation?
That would be something, because (whatever external placebo) the placebo over 10 years is at or near 0%.
It could

Mrs kronwell

Mrs kronwell 56分前

We’ll likely be able to infer more if the replacement the coo position. So either. 1. The President hiring will be mostly offset with coo cost reductions or 2. There was a difference in opinion on direction or execution with the person in that position.

superman2026

superman2026 58分前

Largest shareholder by gifting herself huge shares.

gregcod

gregcod 1時間前

If someone here on this board can go tto that report od AInvest.com/news/ibat.q4-update and copy it and post that report here ..Maybe I should be quiet..but I must ask for the board to post that report here..I dont know how to copy it.im an idiot but someone here can do it!.Its a great report before

t1215s

t1215s 1時間前

Jhd I have a few min.i will reply now “ I believe the 16’s are a lock today (16.09)and then some ,as of this post (8:41AM.) , And that we might hold for the close also AIMHO according to the pre #s”( check the pre numbers on the chart——————->>>>>

I have been told something about alph

Chimera Investment

Supermarket Income REIT

Silver Predator (PK)

Xtrackers S&P 500 Equal ...

Nicholas Nuclear Income ...

iShares AI Innovation Ac...

Invesco ETF Trust II Inv...

State Street SPDR S&P Oi...

Melinta Therapeutics

CG Altria GP Sequins

Torens Series 2014 1

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。